These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28760045)

  • 21. Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.
    Kumar A; Burger IA; Zhang Z; Drill EN; Migliacci JC; Ng A; LaCasce A; Wall D; Witzig TE; Ristow K; Yahalom J; Moskowitz CH; Zelenetz AD
    Haematologica; 2016 Oct; 101(10):1237-1243. PubMed ID: 27390360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and outcome of pediatric patients with stage IV Hodgkin lymphoma.
    Belgaumi A; Al-Kofide AA; Khafaga Y; Joseph N; Jamil-Malik R; Siddiqui KS; Sabbah RS
    Hematol Oncol Stem Cell Ther; 2009; 2(1):278-84. PubMed ID: 20063558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adolescent hodgkin lymphoma: are treatment results more favorable with pediatric than with adult regimens?
    Müller J; Illés A; Molnár Z; Rosta A; Váróczy L; Kovács G
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):e60-3. PubMed ID: 21285900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Features and Prognosis Analysis of Hodgkin Lymphoma: A Multicenter Retrospective Study Over a Decade of Patients in China.
    Yu WY; Geng M; Hao J; Chen M; Zhang SJ; Wang J; Mi JQ
    Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):274-282. PubMed ID: 28292586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of administering pediatric treatment to adolescent patients with mature B-cell non-Hodgkin lymphoma within the Japanese Pediatric Leukemia/Lymphoma Study Group clinical trial.
    Sekimizu M; Hashimoto H; Mori T; Kobayashi R; Horibe K; Tsurusawa M
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27068. PubMed ID: 29637700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of failure after involved field radiation therapy for pediatric and young adult Hodgkin lymphoma.
    Huynh-Le MP; Walker AJ; Kominers SD; Paz-Priel I; Wharam MD; Terezakis SA
    Pediatr Blood Cancer; 2014 Jul; 61(7):1210-4. PubMed ID: 24523203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.
    Hsu SC; Metzger ML; Hudson MM; Pedrosa F; Lins M; Pedrosa M; Barros C; Maciel K; Pui CH; Ribeiro RC; Howard SC
    Pediatr Blood Cancer; 2007 Aug; 49(2):139-44. PubMed ID: 16642484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
    Jalali A; Ha FJ; Chong G; Grigg A; Mckendrick J; Schwarer AP; Doig R; Hamid A; Hawkes EA
    Ann Hematol; 2016 Apr; 95(5):809-16. PubMed ID: 26878861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation.
    Shah GL; Yahalom J; Matasar MJ; Verwys SL; Goldman DA; Bantilan KS; Zhang Z; McCall SJ; Moskowitz AJ; Moskowitz CH
    Br J Haematol; 2016 Nov; 175(3):440-447. PubMed ID: 27377168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
    Schrøder H; Kjeldahl M; Boesen AM; Nielsen OJ; Schmidt K; Johnsen HE; Gregersen H; Heyman M; Gustafsson G
    Dan Med Bull; 2006 Feb; 53(1):76-9. PubMed ID: 16761337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.
    Koumarianou AA; Xiros N; Papageorgiou E; Pectasides D; Economopoulos T
    Anticancer Res; 2007; 27(2):1191-7. PubMed ID: 17465262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
    Hoppe BS; Flampouri S; Zaiden R; Slayton W; Sandler E; Ozdemir S; Dang NH; Lynch JW; Li Z; Morris CG; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1053-1059. PubMed ID: 24928256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol.
    Hallböök H; Gustafsson G; Smedmyr B; Söderhäll S; Heyman M; ;
    Cancer; 2006 Oct; 107(7):1551-61. PubMed ID: 16955505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin lymphoma in Tyrol-a population-based study.
    Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
    Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group.
    Appel BE; Chen L; Buxton A; Wolden SL; Hodgson DC; Nachman JB
    Pediatr Blood Cancer; 2012 Dec; 59(7):1284-9. PubMed ID: 22847767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of pediatric, adolescent, and adult testicular germ cell malignancy.
    Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
    Pediatr Blood Cancer; 2014 Mar; 61(3):446-51. PubMed ID: 24106160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.
    Charpentier AM; Friedman DL; Wolden S; Schwartz C; Gill B; Sykes J; Albert-Green A; Kelly KM; Constine LS; Hodgson DC
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):943-950. PubMed ID: 27869096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.